These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6404173)

  • 21. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 23. [Occurrence of hemolytic disease of the newborn caused by irregular antibodies].
    Mickley H
    Ugeskr Laeger; 1983 Jun; 145(23):1763-5. PubMed ID: 6410568
    [No Abstract]   [Full Text] [Related]  

  • 24. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
    Alie-Daran SJ; Dugoujon JM; Fournie A
    Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
    [No Abstract]   [Full Text] [Related]  

  • 25. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful management of pregnancy and hemolytic disease of the newborn due to anti-HrO in a woman of the D--phenotype.
    Deitenbeck R; Tutschek B; Crombach G; Stannigel H
    Transfusion; 1999 Oct; 39(10):1151-2. PubMed ID: 10532613
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
    Pollock JM; Bowman JM
    Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic disease of the newborn due to maternal irregular antibodies.
    Lin-Chu M; Broadberry RE; Chyou SC; Hung HY; Shen EY; Hsu CH; Ho MY
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):645-8. PubMed ID: 3116152
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irregular antibodies causing hemolytic disease of the newborn.
    Weinstein L
    Obstet Gynecol Surv; 1976 Aug; 31(8):581-91. PubMed ID: 785325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Gualde N
    Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is antenatal antibody screening worthwhile in the Zimbabwean population?
    Cakana AZ; Ngwenya L
    Cent Afr J Med; 2000 Feb; 46(2):38-41. PubMed ID: 14674207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemolytic disease of newborn caused by anti-E antibodies].
    Maszkiewicz W; Ornat K; Podwysocka M
    Pediatr Pol; 1977 Apr; 52(4):445-7. PubMed ID: 405650
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is it advisable to produce anti-Rh0(D) immunoglobulin for the prevention of hemolytic disease of the newborn? (apropos the article by A. A. Mikhaĭlova and N. Ia. Klimova)].
    Olovnikova NI; Chertkov IL
    Gematol Transfuziol; 1993 Mar; 38(3):38-40. PubMed ID: 8020736
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka.
    Mandal S; Malhotra S; Negi G; Tiwari A; Mitra S; Basu S; Singh P
    Immunohematology; 2020 Jun; 36(2):60-63. PubMed ID: 32667819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic disease of the newborn caused by anti-Jkb.
    Merlob P; Litwin A; Reisner SH; Cohen IJ; Zaizov R
    Pediatr Hematol Oncol; 1987; 4(4):357-60. PubMed ID: 3152944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.